Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_assertion type Assertion NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_head.
- NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_assertion description "[Our results showed that the plasmid vectors carrying the TK and TAT-TK fusion protein gene driven by the survivin promoter were successfully constructed and their specific expression in HepG2 cells provided the basis for the targeted gene therapy of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_provenance.
- NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_assertion evidence source_evidence_literature NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_provenance.
- NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_assertion SIO_000772 23354806 NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_provenance.
- NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_assertion wasDerivedFrom befree-20150227 NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_provenance.
- NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_assertion wasGeneratedBy ECO_0000203 NP723225.RASn-KQHP56kwX5bqnK7BpSPEZYHjv6uievCSuMiDFtcE130_provenance.